Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer

<p>Kaplan-Meier curves of (A) overall survival (OS) and (B) progression-free survival (PFS) among patients with complete response (CR) in the combined cohort.</p>

Salvato in:
Dettagli Bibliografici
Autore principale: Rohit Thummalapalli (17314483) (author)
Altri autori: Biagio Ricciuti (14951247) (author), Chaitanya Bandlamudi (15047205) (author), Daniel Muldoon (17314486) (author), Hira Rizvi (16547594) (author), Arielle Elkrief (15055750) (author), Jia Luo (15034764) (author), Joao V. Alessi (17314489) (author), Federica Pecci (15561470) (author), Giuseppe Lamberti (15024714) (author), Alessandro Di Federico (15561473) (author), Lingzhi Hong (17314492) (author), Jianjun Zhang (16041833) (author), John V. Heymach (14934698) (author), Don L. Gibbons (15055721) (author), Andrew J. Plodkowski (15028415) (author), Vignesh Ravichandran (15052350) (author), Mark T.A. Donoghue (15054209) (author), Chad Vanderbilt (15050973) (author), Marc Ladanyi (15050661) (author), Charles M. Rudin (11572933) (author), Mark G. Kris (15055774) (author), Gregory J. Riely (14961725) (author), Jamie E. Chaft (14937195) (author), Matthew D. Hellmann (14937198) (author), Natalie I. Vokes (17314495) (author), Mark M. Awad (14961722) (author), Adam J. Schoenfeld (15022025) (author)
Pubblicazione: 2025
Soggetti:
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1849927631393259520
author Rohit Thummalapalli (17314483)
author2 Biagio Ricciuti (14951247)
Chaitanya Bandlamudi (15047205)
Daniel Muldoon (17314486)
Hira Rizvi (16547594)
Arielle Elkrief (15055750)
Jia Luo (15034764)
Joao V. Alessi (17314489)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Lingzhi Hong (17314492)
Jianjun Zhang (16041833)
John V. Heymach (14934698)
Don L. Gibbons (15055721)
Andrew J. Plodkowski (15028415)
Vignesh Ravichandran (15052350)
Mark T.A. Donoghue (15054209)
Chad Vanderbilt (15050973)
Marc Ladanyi (15050661)
Charles M. Rudin (11572933)
Mark G. Kris (15055774)
Gregory J. Riely (14961725)
Jamie E. Chaft (14937195)
Matthew D. Hellmann (14937198)
Natalie I. Vokes (17314495)
Mark M. Awad (14961722)
Adam J. Schoenfeld (15022025)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Rohit Thummalapalli (17314483)
Biagio Ricciuti (14951247)
Chaitanya Bandlamudi (15047205)
Daniel Muldoon (17314486)
Hira Rizvi (16547594)
Arielle Elkrief (15055750)
Jia Luo (15034764)
Joao V. Alessi (17314489)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Lingzhi Hong (17314492)
Jianjun Zhang (16041833)
John V. Heymach (14934698)
Don L. Gibbons (15055721)
Andrew J. Plodkowski (15028415)
Vignesh Ravichandran (15052350)
Mark T.A. Donoghue (15054209)
Chad Vanderbilt (15050973)
Marc Ladanyi (15050661)
Charles M. Rudin (11572933)
Mark G. Kris (15055774)
Gregory J. Riely (14961725)
Jamie E. Chaft (14937195)
Matthew D. Hellmann (14937198)
Natalie I. Vokes (17314495)
Mark M. Awad (14961722)
Adam J. Schoenfeld (15022025)
author_role author
dc.creator.none.fl_str_mv Rohit Thummalapalli (17314483)
Biagio Ricciuti (14951247)
Chaitanya Bandlamudi (15047205)
Daniel Muldoon (17314486)
Hira Rizvi (16547594)
Arielle Elkrief (15055750)
Jia Luo (15034764)
Joao V. Alessi (17314489)
Federica Pecci (15561470)
Giuseppe Lamberti (15024714)
Alessandro Di Federico (15561473)
Lingzhi Hong (17314492)
Jianjun Zhang (16041833)
John V. Heymach (14934698)
Don L. Gibbons (15055721)
Andrew J. Plodkowski (15028415)
Vignesh Ravichandran (15052350)
Mark T.A. Donoghue (15054209)
Chad Vanderbilt (15050973)
Marc Ladanyi (15050661)
Charles M. Rudin (11572933)
Mark G. Kris (15055774)
Gregory J. Riely (14961725)
Jamie E. Chaft (14937195)
Matthew D. Hellmann (14937198)
Natalie I. Vokes (17314495)
Mark M. Awad (14961722)
Adam J. Schoenfeld (15022025)
dc.date.none.fl_str_mv 2025-11-25T13:44:47Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30710434
dc.relation.none.fl_str_mv https://figshare.com/articles/figure/Supplementary_Figure_S5_from_Clinical_and_Molecular_Features_of_Long-term_Response_to_Immune_Checkpoint_Inhibitors_in_Patients_with_Advanced_Non_Small_Cell_Lung_Cancer/30710434
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Clinical Research and Trials
Biomarkers
Prognostic biomarkers
Immunotherapy
Biomarkers for immunotherapy
Checkpoint blockade
Lung Cancer
Precision Medicine
dc.title.none.fl_str_mv Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
dc.type.none.fl_str_mv Image
Figure
info:eu-repo/semantics/publishedVersion
image
description <p>Kaplan-Meier curves of (A) overall survival (OS) and (B) progression-free survival (PFS) among patients with complete response (CR) in the combined cohort.</p>
eu_rights_str_mv openAccess
id Manara_01b472c72a74ee700fe4638a45d71fb5
identifier_str_mv 10.1158/1078-0432.30710434
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30710434
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung CancerRohit Thummalapalli (17314483)Biagio Ricciuti (14951247)Chaitanya Bandlamudi (15047205)Daniel Muldoon (17314486)Hira Rizvi (16547594)Arielle Elkrief (15055750)Jia Luo (15034764)Joao V. Alessi (17314489)Federica Pecci (15561470)Giuseppe Lamberti (15024714)Alessandro Di Federico (15561473)Lingzhi Hong (17314492)Jianjun Zhang (16041833)John V. Heymach (14934698)Don L. Gibbons (15055721)Andrew J. Plodkowski (15028415)Vignesh Ravichandran (15052350)Mark T.A. Donoghue (15054209)Chad Vanderbilt (15050973)Marc Ladanyi (15050661)Charles M. Rudin (11572933)Mark G. Kris (15055774)Gregory J. Riely (14961725)Jamie E. Chaft (14937195)Matthew D. Hellmann (14937198)Natalie I. Vokes (17314495)Mark M. Awad (14961722)Adam J. Schoenfeld (15022025)CancerCancer Detection and DiagnosisImmuno-oncologyClinical Research and TrialsBiomarkersPrognostic biomarkersImmunotherapyBiomarkers for immunotherapyCheckpoint blockadeLung CancerPrecision Medicine<p>Kaplan-Meier curves of (A) overall survival (OS) and (B) progression-free survival (PFS) among patients with complete response (CR) in the combined cohort.</p>2025-11-25T13:44:47ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30710434https://figshare.com/articles/figure/Supplementary_Figure_S5_from_Clinical_and_Molecular_Features_of_Long-term_Response_to_Immune_Checkpoint_Inhibitors_in_Patients_with_Advanced_Non_Small_Cell_Lung_Cancer/30710434CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307104342025-11-25T13:44:47Z
spellingShingle Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Rohit Thummalapalli (17314483)
Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Clinical Research and Trials
Biomarkers
Prognostic biomarkers
Immunotherapy
Biomarkers for immunotherapy
Checkpoint blockade
Lung Cancer
Precision Medicine
status_str publishedVersion
title Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_full Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_fullStr Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_full_unstemmed Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_short Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
title_sort Supplementary Figure S5 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
topic Cancer
Cancer Detection and Diagnosis
Immuno-oncology
Clinical Research and Trials
Biomarkers
Prognostic biomarkers
Immunotherapy
Biomarkers for immunotherapy
Checkpoint blockade
Lung Cancer
Precision Medicine